Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Insurance reimbursement for risk-reducing mastectomy and oophorectomy in women with BRCA1 or BRCA2 mutations.

Genetics in medicine : official journal of the American College of Medical Genetics - 1 Jan 2000

Kauff N D, Scheuer L, Robson M E, Glogowski E, Kelly B, Barakat R, Heerdt A, Borgen P I, Davis J G, Offit K

Abstract excerpt

PURPOSE: Risk-reducing surgery is an important option for women with BRCA1 and BRCA2 mutations. There are reports in the literature that insurance reimbursement for these procedures varies greatly. Because health insurance coverage significantly affects medical decision-making, current information regarding reimbursement practices of third-party payers is needed. METHODS: Retrospective study of hospital billing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA2 Protein
Share to Decision Making

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Genetic Counseling

Share to Mastectomy

Share to New York

Share to Ovarian Neoplasms

Share to Ovariectomy

Source

Identifiers

PMID: 11715007
DOI: 10.1097/00125817-200111000-00008

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Insurance reimbursement for risk-reducing mastectomy and oophorectomy in women with BRCA1 or BRCA2 mutations.PMID 11715007Read ↗

Cost-effectiveness of risk-reducing surgeries in preventing hereditary breast and ovarian cancer.Semantic proximity Read ↗

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.Semantic proximity Read ↗

Clinical characteristics and choices regarding risk-reducing surgery in BRCA mutation carriers.Semantic proximity Read ↗

Health care provider recommendations for reducing cancer risks among women with a BRCA1 or BRCA2 mutation.Semantic proximity Read ↗

BRCA1/2 mutation carriers & risk reducing mastectomy: Who undergoes surgery and potential benefits.Semantic proximity Read ↗

Surgical and financial implications of genetic counseling and requests for concurrent prophylactic mastectomy.Semantic proximity Read ↗

Oophorectomy for breast cancer prevention in women with BRCA1 or BRCA2 mutations.Semantic proximity Read ↗

Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation.Semantic proximity Read ↗

Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations.Semantic proximity Read ↗

Rates of risk-reducing surgery in Israeli BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

The frequency and outcome of breast cancer risk-reducing surgery in Finnish BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Estimation of healthcare-related charges in women with BRCA mutations and breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.